IMCD stock trades close to EUR95 with double-digit year-to-date gains

IMCD (ISIN NL0010801007) stock is trading at a consolidated price level around EUR95 on European venues as of August 21, 2026, giving investors a clear reference point for valuing the specialty chemicals distributor after its most recent reporting cycle.

Shares consolidate around the EUR95 mark

Recent market data compiled on August 21, 2026 show IMCD shares quoted at EUR95.50 on the German Tradegate platform and EUR95.62 on Euronext Amsterdam, with both venues indicating modest intraday gains of 0.10 percent and 0.17 percent respectively. A detailed trading overview from a European market report highlights that the stock has delivered a year-to-date performance of 23 percent as of August 21, 2026, underscoring that the current quotation in the mid-EUR90s sits on top of a substantial advance since the beginning of the year.

The same overview notes that the share price is holding at a specific band around EUR95.50 on August 21, 2026, which market observers treat as a psychological reference level for the stock at this stage of the year. With the Tradegate quote at EUR95.50 and the Euronext Amsterdam quote at EUR95.62 on August 21, 2026, IMCD stock shows a tight spread between trading venues and a calm intraday picture, even after a strong double-digit rise since January.

Year-to-date performance and recent fundamentals

The year-to-date gain of 23 percent as of August 21, 2026 is a key comparison for investors evaluating IMCD stock against broader European equity benchmarks and peers in chemical distribution, since it implies that shareholders have seen more than twice the return of a typical high-single-digit index move over the same period. The same European market article stresses that this upward trajectory reflects investors' confidence in the company’s ability to grow volumes and maintain margins in its specialty chemicals distribution model.

In the latest half-year reporting period, which ended within the past few months of 2026, IMCD presented financial figures that support this share-price resilience, including higher revenue and improved profitability compared with the prior year interval. Per the most recent investor communication, revenue for the latest half-year was higher than in the previous year’s comparable period, with operating profit and net income also up on a year-on-year basis, confirming that the company is monetizing growth in demand for specialized formulations and additives through its network of suppliers and customers.

Investors have paid particular attention to the margin trend in the latest half-year report, where management indicated a positive development in gross margin and operating margin compared with the prior year period. This improvement in profitability metrics, combined with the reported revenue growth, offers a tangible explanation for why IMCD shares are trading firmly around EUR95 in August 2026 rather than retracing more of their year-to-date gains. A comparison between the current margin level and the previous year’s margin underscores that the company is able to pass on value-added services and maintain pricing power in a competitive marketplace.

Distribution model and specialty product portfolio

For IMCD, the numbers tie directly into its core business of distributing specialty chemicals, ingredients and advanced formulations to industrial and consumer end markets. The company’s asset-light distribution model centers on matching chemical producers with downstream users, providing technical support and formulation expertise that can justify higher margins than simple commodity trading. In the latest reporting period, growth in volumes and a richer product mix contributed to the higher revenue and profit figures that investors now use as a backdrop when assessing the stock’s valuation around EUR95.

A representative example within IMCD’s portfolio is its range of specialty additives and formulation aids for coatings and construction materials, where the company combines products from multiple suppliers into tailored solutions. The ability to bundle such specialty products and support customers in adapting formulations to regulatory and performance requirements helped drive the margin improvement reported in the most recent half-year figures. As the company continues to expand this type of value-added product offering, investors will monitor whether the revenue and margin trends seen in the latest reporting period can be sustained into the next quarter.

IMCD shares and current valuation level

At trading levels of EUR95.50 on Tradegate and EUR95.62 on Euronext Amsterdam as of August 21, 2026, IMCD shares are positioned meaningfully above the reference price of EUR78.78 that was recorded in the closing auction on Euronext Amsterdam on August 20, 2026. An earlier corporate-news overview cited the EUR78.78 close on August 20, 2026 at 5:35 p.m. local time, and investors can therefore observe that the subsequent move into the mid-EUR90s represents a noticeable step up relative to that prior level.

For retail investors, the coincidence of a 23 percent year-to-date gain as of August 21, 2026 and the recent lift from EUR78.78 on August 20, 2026 to around EUR95.62 on August 21, 2026 highlights how IMCD’s latest fundamentals and expectations have translated into market pricing. While the article detailing the EUR78.78 close emphasized stability in the share price after the last reporting cycle, the newer readings at EUR95 and higher year-to-date performance figures suggest that the market is now pricing in stronger medium-term prospects for the specialty chemicals distribution model, including sustained revenue growth and firm margins.

Go deeper

More on IMCD stock and investor communications can be found via the company’s investor relations resources, where recent presentations, financial statements and outlook comments give further detail on segment performance, geographic expansion and management’s strategy for balancing growth and profitability.

Investor Relations

Visit the investor relations section for IMCD to review the latest half-year and annual reports, earnings presentations and governance information that underpin the revenue, profit and margin figures referenced here.

Fact box

Company: IMCD N.V.

ISIN: NL0010801007

Ticker: IMCD

Exchange: Euronext Amsterdam

Price (as of August 21, 2026, close): EUR95.62

Sector / Industry: Chemicals distribution and specialty ingredients